Analysis of copy number variation in Alzheimer's disease

The NIALOAD/ NCRAD family study

Shanker Swaminathan, Li Shen, Sungeun Kim, Mark Inlow, John D. West, Kelley M. Faber, Tatiana Foroud, Richard Mayeux, Andrew Saykin

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Copy number variants (CNVs) are DNA regions that have gains (duplications) or losses (deletions) of genetic material. CNVs may encompass a single gene or multiple genes and can affect their function. They are hypothesized to play an important role in certain diseases. We previously examined the role of CNVs in late-onset Alzheimer's disease (AD) and mild cognitive impairment (MCI) using participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study and identified gene regions overlapped by CNVs only in cases (AD and/or MCI) but not in controls. Using a similar approach as ADNI, we investigated the role of CNVs using 794 AD and 196 neurologically evaluated control non-Hispanic Caucasian NIA-LOAD/NCRAD Family Study participants with DNA derived from blood/brain tissue. The controls had no family history of AD and were unrelated to AD participants. CNV calls were generated and analyzed after detailed quality review. 711 AD cases and 171 controls who passed all quality thresholds were included in case/control association analyses, focusing on candidate gene and genome-wide approaches. We identified genes overlapped by CNV calls only in AD cases but not controls. A trend for lower CNV call rate was observed for deletions as well as duplications in cases compared to controls. Gene-based association analyses confirmed previous findings in the ADNI study (ATXN1, HLA-DPB1, RELN, DOPEY2, GSTT1, CHRFAM7A, ERBB4, NRXN1) and identified a new gene (IMMP2L) that may play a role in AD susceptibility. Replication in independent samples as well as further analyses of these gene regions is warranted.

Original languageEnglish
Pages (from-to)801-814
Number of pages14
JournalCurrent Alzheimer Research
Volume9
Issue number7
DOIs
StatePublished - 2012

Fingerprint

Alzheimer Disease
Genes
Neuroimaging
DNA Copy Number Variations
Gene Dosage
Disease Susceptibility
Genome
DNA
Brain

Keywords

  • Alzheimer's disease
  • Association study
  • CHRFAM7A
  • Copy number variation
  • Dementia
  • IMMP2L
  • NCRAD
  • NIALOAD
  • Replication

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Analysis of copy number variation in Alzheimer's disease : The NIALOAD/ NCRAD family study. / Swaminathan, Shanker; Shen, Li; Kim, Sungeun; Inlow, Mark; West, John D.; Faber, Kelley M.; Foroud, Tatiana; Mayeux, Richard; Saykin, Andrew.

In: Current Alzheimer Research, Vol. 9, No. 7, 2012, p. 801-814.

Research output: Contribution to journalArticle

Swaminathan, Shanker ; Shen, Li ; Kim, Sungeun ; Inlow, Mark ; West, John D. ; Faber, Kelley M. ; Foroud, Tatiana ; Mayeux, Richard ; Saykin, Andrew. / Analysis of copy number variation in Alzheimer's disease : The NIALOAD/ NCRAD family study. In: Current Alzheimer Research. 2012 ; Vol. 9, No. 7. pp. 801-814.
@article{152dad8ddf7c4a8ba8fd86c39fc209a0,
title = "Analysis of copy number variation in Alzheimer's disease: The NIALOAD/ NCRAD family study",
abstract = "Copy number variants (CNVs) are DNA regions that have gains (duplications) or losses (deletions) of genetic material. CNVs may encompass a single gene or multiple genes and can affect their function. They are hypothesized to play an important role in certain diseases. We previously examined the role of CNVs in late-onset Alzheimer's disease (AD) and mild cognitive impairment (MCI) using participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study and identified gene regions overlapped by CNVs only in cases (AD and/or MCI) but not in controls. Using a similar approach as ADNI, we investigated the role of CNVs using 794 AD and 196 neurologically evaluated control non-Hispanic Caucasian NIA-LOAD/NCRAD Family Study participants with DNA derived from blood/brain tissue. The controls had no family history of AD and were unrelated to AD participants. CNV calls were generated and analyzed after detailed quality review. 711 AD cases and 171 controls who passed all quality thresholds were included in case/control association analyses, focusing on candidate gene and genome-wide approaches. We identified genes overlapped by CNV calls only in AD cases but not controls. A trend for lower CNV call rate was observed for deletions as well as duplications in cases compared to controls. Gene-based association analyses confirmed previous findings in the ADNI study (ATXN1, HLA-DPB1, RELN, DOPEY2, GSTT1, CHRFAM7A, ERBB4, NRXN1) and identified a new gene (IMMP2L) that may play a role in AD susceptibility. Replication in independent samples as well as further analyses of these gene regions is warranted.",
keywords = "Alzheimer's disease, Association study, CHRFAM7A, Copy number variation, Dementia, IMMP2L, NCRAD, NIALOAD, Replication",
author = "Shanker Swaminathan and Li Shen and Sungeun Kim and Mark Inlow and West, {John D.} and Faber, {Kelley M.} and Tatiana Foroud and Richard Mayeux and Andrew Saykin",
year = "2012",
doi = "10.2174/156720512802455331",
language = "English",
volume = "9",
pages = "801--814",
journal = "Current Alzheimer Research",
issn = "1567-2050",
publisher = "Bentham Science Publishers B.V.",
number = "7",

}

TY - JOUR

T1 - Analysis of copy number variation in Alzheimer's disease

T2 - The NIALOAD/ NCRAD family study

AU - Swaminathan, Shanker

AU - Shen, Li

AU - Kim, Sungeun

AU - Inlow, Mark

AU - West, John D.

AU - Faber, Kelley M.

AU - Foroud, Tatiana

AU - Mayeux, Richard

AU - Saykin, Andrew

PY - 2012

Y1 - 2012

N2 - Copy number variants (CNVs) are DNA regions that have gains (duplications) or losses (deletions) of genetic material. CNVs may encompass a single gene or multiple genes and can affect their function. They are hypothesized to play an important role in certain diseases. We previously examined the role of CNVs in late-onset Alzheimer's disease (AD) and mild cognitive impairment (MCI) using participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study and identified gene regions overlapped by CNVs only in cases (AD and/or MCI) but not in controls. Using a similar approach as ADNI, we investigated the role of CNVs using 794 AD and 196 neurologically evaluated control non-Hispanic Caucasian NIA-LOAD/NCRAD Family Study participants with DNA derived from blood/brain tissue. The controls had no family history of AD and were unrelated to AD participants. CNV calls were generated and analyzed after detailed quality review. 711 AD cases and 171 controls who passed all quality thresholds were included in case/control association analyses, focusing on candidate gene and genome-wide approaches. We identified genes overlapped by CNV calls only in AD cases but not controls. A trend for lower CNV call rate was observed for deletions as well as duplications in cases compared to controls. Gene-based association analyses confirmed previous findings in the ADNI study (ATXN1, HLA-DPB1, RELN, DOPEY2, GSTT1, CHRFAM7A, ERBB4, NRXN1) and identified a new gene (IMMP2L) that may play a role in AD susceptibility. Replication in independent samples as well as further analyses of these gene regions is warranted.

AB - Copy number variants (CNVs) are DNA regions that have gains (duplications) or losses (deletions) of genetic material. CNVs may encompass a single gene or multiple genes and can affect their function. They are hypothesized to play an important role in certain diseases. We previously examined the role of CNVs in late-onset Alzheimer's disease (AD) and mild cognitive impairment (MCI) using participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study and identified gene regions overlapped by CNVs only in cases (AD and/or MCI) but not in controls. Using a similar approach as ADNI, we investigated the role of CNVs using 794 AD and 196 neurologically evaluated control non-Hispanic Caucasian NIA-LOAD/NCRAD Family Study participants with DNA derived from blood/brain tissue. The controls had no family history of AD and were unrelated to AD participants. CNV calls were generated and analyzed after detailed quality review. 711 AD cases and 171 controls who passed all quality thresholds were included in case/control association analyses, focusing on candidate gene and genome-wide approaches. We identified genes overlapped by CNV calls only in AD cases but not controls. A trend for lower CNV call rate was observed for deletions as well as duplications in cases compared to controls. Gene-based association analyses confirmed previous findings in the ADNI study (ATXN1, HLA-DPB1, RELN, DOPEY2, GSTT1, CHRFAM7A, ERBB4, NRXN1) and identified a new gene (IMMP2L) that may play a role in AD susceptibility. Replication in independent samples as well as further analyses of these gene regions is warranted.

KW - Alzheimer's disease

KW - Association study

KW - CHRFAM7A

KW - Copy number variation

KW - Dementia

KW - IMMP2L

KW - NCRAD

KW - NIALOAD

KW - Replication

UR - http://www.scopus.com/inward/record.url?scp=84866687636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866687636&partnerID=8YFLogxK

U2 - 10.2174/156720512802455331

DO - 10.2174/156720512802455331

M3 - Article

VL - 9

SP - 801

EP - 814

JO - Current Alzheimer Research

JF - Current Alzheimer Research

SN - 1567-2050

IS - 7

ER -